DJIA 17,356.87 288.00 1.69%
NASDAQ 4,644.31 96.48 2.12%
S&P 500 2,012.89 40.15 2.04%
market minute promo


company name or ticker

Pluristem's Positive Data Could Open Massive Muscle Injury Market

Pluristem Touches 52-Week High - Analyst Blog

Pluristem Touches 52-Week High - Analyst Blog

Pluristem (PSTI) Jumps: Stock Adds 8.6% in Session - Tale of the Tape

Sector Update: Healthcare Shares Flat; Pluristem Therapeutics up 4% on Partnership with CHA Bio & Di

Sector Update: Healthcare Shares Flat; Pluristem Therapeutics up 4% on Partnership with CHA Bio & Diostech

Sector Update: Healthcare

US Stock Futures Flat Ahead Of Fed

Pluristem Issues 2.5M Shares in Exchange for 1.011M Shares of CHA

Why Sinovac, Pluristem, and Synta Could Be Worth Watching Today

Sinovac, Pluristem, and Synta Pharmaceuticals might all be worth a look today. Let's take a look at the headlines that could move these three stocks.

Pluristem Receives Regulatory Korean Approval to Extend Phase II Study of PLX-PAD Cells for Treatmen

Pluristem Receives Regulatory Korean Approval to Extend Phase II Study of PLX-PAD Cells for Treatment of IC

Pluristem Announces Safety of PLX Cells in Pre-Clinical Pregnancy Model

See More Articles...